Form D · Biotechnology
Sienna Biopharmaceuticals, Inc.
Weslake Village, CA · CIK 0001656328
Offering snapshot reported May 15, 2017 · SEC filing
- Reported sold
- $46.6M Offering amount: $50M
- Investors reported
- 91 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 8, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$18,466,888 → $46,630,453
- Reported investors12 → 91
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2017 | Amendment | $46,630,453 | $28,163,565vs Oct 20, 2015 | 91 | SEC filing |
| May 15, 2017 | Initial | $40,471,910 | No comparison | 29 | SEC filing |
| Oct 20, 2015 | Initial | $18,466,888 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-249771
Includes $13,466,889.21 cancellation of debt
Source: Form D, filed May 15, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy K. Andrews | Executive |
| Frederick Beddingfield | Director |
| Frederick C. Beddingfield Iii | Director, Executive |
| Kristina Burow | Director |
| Dennis Fenton | Director |
| Todd Harris | Director, Executive |
| Keith R. Leonard Jr. | Director |
| Paul F. Lizzul | Executive |
| Robert More | Director, Executive |
| Bob More | Director |
| Robert Nelsen | Director |
| Robert Nelson | Director |
| Ric Peterson | Executive |
| Ted Schwarz | Executive |
| Diane Stroehmann | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
30699 Russell Ranch Road Suite 140
Weslake Village, CA, 91362
Weslake Village, CA, 91362